14 results
·
19ms
·
Sources: EU EUDAMED, US FDA
EVER-SHARP BIOPSY FORCEPS
FDA 510(k)
FDA Class 1
·Obstetrics/Gynecology
Snowden-Pencer
FDA UDI
STERIS CORPORATION·10885403278624·Snowden-Pencer MIS SWITCH-BLADE MINI METZENBAUM...
N/A
FDA UDI
STRYKER SUSTAINABILITY SOLUTIONS, INC.·00885825018009·Curved Mini Metzenbaum Scissor Tip
Arthrex®
FDA UDI
ARTHREX, INC.·00888867055131·PLATE, POW, LOCKING, TI, 3 MM
UNKNOWN V. MUELLER DEVICE
FDA Adverse Event
Injury
·CAREFUSION·Product code GEI·March 23, 2015
OPTI-TEARS(R)
FDA 510(k)
FDA Class 2
·Ophthalmic
NON-STERILE PATIENT EXAMINATION GLOVES
FDA 510(k)
FDA Class 1
·General Hospital
4.0MM TI LOCKING SCREW W/T25 STARDRIVE 20MM F/IM NAILS-STER
FDA Adverse Event
Malfunction
·SYNTHES MONUMENT·Product code HSB·January 23, 2014
G4 PLATINUM CONTINUOUS GLUCOSE MONITORING SYSTEM
FDA Adverse Event
Malfunction
·DEXCOM, INC.·Product code MDS·June 25, 2014
VENT TUBE 1016010 5PK GOODE T 1.14X12MM
FDA Adverse Event
Injury
·XOMED MFG JACKSONVILLE·Product code ETD·January 3, 2013
INTERSTIM
FDA Adverse Event
Injury
·MEDTORNIC NEUROMODULATION·Product code EZW·November 8, 2010
SWITCH-BLADE CLICKFIT REUSE HNDL 5MM36CM
FDA Adverse Event
Malfunction
·CAREFUSION·Product code GEI·October 5, 2011
Pipeline Flex Embolization Device
FDA Enforcement
Class I
·Ongoing·Micro Therapeutics Inc,·September 15, 2021
Assurity Model Numbers: PM1240, PM2240; Assurity + Model Number: PM2260; Accent Model Numbers: PM1210, PM2210, PM1222, PM2212; Accent MRI Model Numbers: PM1224, PM2218, PM2224 Implantation of a single-chamber pulse generator, dual-chamber pulse generator, or CRT-P is indicated in one or more of the following permanent conditions: Syncope, Presyncope, Fatigue, Disorientation, Or any combination of those symptoms. Implantation of a CRT-P is indicated for: Maintaining synchrony of the left and right ventricles in patients who have undergone an AV nodal ablation for chronic atrial fibrillation and have NYHA Class II or III heart failure. The reduction of the symptoms of moderate to severe heart failure (NYHA Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy, and have a left ventricular ejection fraction d35% and a prolonged QRS duration
FDA Enforcement
Class II
·Terminated·St Jude Medical Inc.·October 25, 2017